1H, 13C, and 15N backbone and side-chain chemical shift assignments for the 29 kDa human galectin-1 protein dimer

Barondes SH, Castronovo V, Cooper DNW, Cummings RD, Drickamer K, Felzi T et al (1994) Galectins: a family of animal beta-galactoside-binding lectins. Cell 76:597–598. doi: 10.1016/0092-8674(94)90498-7

Camby I, Le Mercier M, Lefranc F, Kiss R (2006) Galectin-1: a small protein with major functions. Glycobiology 16:137R–157R. doi: 10.1093/glycob/cwl025

Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6:277–293. doi: 10.1007/BF00197809

Griffioen AW, van der Schaft DW, Barendsz-Janson AF, Cox A, Struijker Boudier HA, Hillen HF et al (2001) Anginex, a designed peptide that inhibits angiogenesis. Biochem J 354:233–242. doi: 10.1042/0264-6021:3540233

Johnson BA (2004) Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol Biol 278:313–352

Leffler H (2001) Galectins structure and function—a synopsis. Results Probl Cell Differ 33:57–83

López-Lucendo MF, Solís D, André S, Hirabayashi J, Kasai K, Kaltner H et al (2004) Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J Mol Biol 343:957–970. doi: 10.1016/j.jmb.2004.08.078

Mayo KH, Dings RP, Flader C, Nesmelova I, Hargittai B, van der Schaft DW et al (2003) Design of a partial-peptide mimetic of anginex with antiangiogenic and anticancer activity. J Biol Chem 278:45746–45752. doi: 10.1074/jbc.M308608200

Muhandiram DR, Kay LE (1994) Gradient-enhanced triple-resonance three-dimensional NMR experiments with improved sensitivity. J Magn Reson B103:203–216

Pace KE, Hahn HP, Baum LG (2003) Preparation of recombinant human galectin-1 and use in T-cell death assays. Methods Enzymol 363:499–518. doi: 10.1016/S0076-6879(03)01075-9

Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S et al (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 103:15975–15980. doi: 10.1073/pnas.0603883103

Thijssen VL, Poirier F, Baum LG, Griffioen AW (2007) Galectins in the tumor endothelium: opportunities for combined cancer therapy. Blood 110:2819–2827. doi: 10.1182/blood-2007-03-077792